On this month's episode rare diseases are discussed. Including the difficulties in diagnosing these rare disease and the importance of research in developing effective treatments. On this episode, Dr. Bradley Schlaggar, president and CEO of Kennedy Krieger Institute welcomes: Dr. Ali Fatemi - Chief Medical Officer at Kennedy Krieger Institute and Director of the Moser Center for Leukodystrophies and an investigator at the Hugo W. Moser Research Institute at Kennedy Krieger. Dr. Fatemi is also professor of neurology and pediatrics at Johns Hopkins School of Medicine. Dr. Erika Augustine - Associate Chief Science Officer and the Director of the Clinical Trials Unit at Kennedy Krieger Institute, as well as the Director of the Batten Disease Clinic at Kennedy Krieger. Dr. Augustine is also an associate professor of Neurology at Johns Hopkins School of Medicine. Links to visit: https://rarediseases.org/ https://www.kennedykrieger.org/stories/news-and-updates/research-news-releases/kennedy-krieger-named-center-excellence-its-treatment-rare-pediatric-diseases See omnystudio.com/listener for privacy information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast